Akihiro Bessho

Non–Small Cell Lung Cancer Cells Acquire Resistance to the ALK Inhibitor Alectinib by Activating Alternative Receptor Tyrosine Kinases

Hideko Isozaki, Eiki Ichihara, Nagio Takigawa et al. · Cancer Research · 2016 · 128 citations · Full text

Oncology, Medicine, Receptor Tyrosine Kinase +15

Phase II Trial of Gefitinib in Combination with Bevacizumab as First-Line Therapy for Advanced Non–Small Cell Lung Cancer with Activating EGFR Gene Mutations: The Okayama Lung Cancer Study Group Trial 1001

Eiki Ichihara, Katsuyuki Hotta, Naoyuki Nogami et al. · Journal of Thoracic Oncology · 2015 · 103 citations

First-line Therapy, Phase Ii Trial, Medicine +8

The effects of a simplified method for cryopreservation and thawing procedures on peripheral blood stem cells

Yoshio Katayama, Tomonori Yano, Akihiro Bessho et al. · Bone Marrow Transplantation · 1997 · 95 citations

Simplified Method, Thawing Procedures, Medicine +12

Interstitial Lung Disease in Japanese Patients With Non-Small Cell Lung Cancer Receiving Gefitinib

Katsuyuki Hotta, Katsuyuki Kiura, Masahiro Tabata et al. · The Cancer Journal · 2005 · 75 citations

Comparison of the Incidence and Pattern of Interstitial Lung Disease During Erlotinib and Gefitinib Treatment in Japanese Patients with Non-small Cell Lung Cancer: The Okayama Lung Cancer Study Group Experience

Katsuyuki Hotta, Katsuyuki Kiura, Nagio Takigawa et al. · Journal of Thoracic Oncology · 2010 · 72 citations · Full text

Medicine, Pathology, Bronchial Neoplasm +6